Docking studies of a Triazole-based Chalcone on Various Matrix Metalloproteinases | ||
| Alexandria Journal of Science and Technology | ||
| Articles in Press, Accepted Manuscript, Available Online from 17 January 2025 PDF (1.32 M) | ||
| Document Type: Research article | ||
| DOI: 10.21608/ajst.2025.347755.1059 | ||
| Authors | ||
| Omar A. Soliman1; Kholoud Khaled Debes2; Nesreen Saied3; Reda M. Keshk2; Doha M. Beltagy4; Mohamed Teleb* 5; Abdel Moneim El Massry6; Sherine N Khattab6 | ||
| 1Department of Clinical Pharmacy, Alexandria University Main Teaching Hospital, Alexandria, Egypt. Department of Human Genetics, Medical Research Institute, Alexandria University, Alexandria, Egypt. | ||
| 2Chemistry Department, Faculty of Science, Damanhour University, Damanhour 22511, Egypt. | ||
| 3Department of Physics and Chemistry, Faculty of Education, Alexandria University, Egypt | ||
| 4Biochemistry Department, Faculty of Science, Damanhour University, Damanhour 22511, Egypt. | ||
| 5Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt | ||
| 6Chemistry Department, Faculty of Science, Alexandria University, Alexandria 21321, Egypt | ||
| Abstract | ||
| Docking is a powerful tool that has been validated for lead optimization. Cancer research has been always concerned with matrix metalloproteinases (MMPs) inhibition being a validated druggable target that is implicated in almost all stages of carcinogenesis. Therefore, optimization of lead inhibitors is of utmost importance. The present study explores the possible binding modes of a novel triazole-based chalcone into various MMPs catalytic domains in attempt to explore its potential as possible MMP inhibitors, identify its isoform selectivity and deduce the structural determinants of activity within the scaffold. The investigated chalcone, referred to as compound 3, demonstrated preferential binding to MMP-9 and MMP-13 in terms of favorable binding energies (-11.92 and -11.25 kcal/mol), inhibition constants (1.82 and 5.65 nM), electrostatic (-0.38 and -0.14 Kcal/mol) and vdW (-13.63 and -13.32 Kcal/mol, respectively) interactions referring to its potential utility for targeted selective tumor-associated MMPs inhibition. These results encourage further research to evaluate the compound’s in vitro potency of the studied compound against MMP-9 and MMP-13 and sensitive cancer cell lines. | ||
| Keywords | ||
| Molecular Modelling; Docking; MMPs; Cancer; Azoles | ||
|
Supplementary Files
|
||
|
Statistics Article View: 111 PDF Download: 133 |
||
